Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2022-08-05 Governance Information
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
马应龙公司章程（2022年8月修订）
Governance Information Classification · 100% confidence The document is titled as the "公司章程" (Company Articles of Association) for 马应龙药业集团股份有限公司, revised in August 2022. It contains detailed provisions on company governance, shareholder rights, board of directors, management, share issuance, shareholder meetings, voting procedures, and other corporate governance matters. It is a comprehensive internal governance document rather than a financial report or announcement. It does not contain financial statements, earnings data, or audit results. It is not an announcement or a proxy solicitation but the actual corporate charter. Therefore, it fits the category of Governance Information (CGR). The document length (15,000 characters) and content confirm it is the full governance document, not a brief announcement or summary.
2022-08-05 Chinese
马应龙2021年年度权益分派实施公告
Notice of Dividend Amount Classification · 100% confidence The document is an announcement regarding the implementation of the 2021 annual dividend distribution by the company 马应龙药业集团股份有限公司. It details the dividend per share, relevant dates for dividend entitlement and payment, tax withholding policies, and contact information for inquiries. It references the approval of the dividend distribution at the 2022 shareholders' meeting but does not contain financial statements or comprehensive financial performance data. The document is focused on dividend payment details rather than the full annual report or earnings release. Therefore, it fits the category of a Notice of Dividend Amount (DIV). The document length is short and specific to dividend distribution, confirming this classification.
2022-07-19 Chinese
马应龙关于召开2021年度暨2022年第一季度业绩说明会的公告
Regulatory Filings Classification · 90% confidence The document is an announcement about the scheduling and details of an upcoming earnings explanation meeting (业绩说明会) for the 2021 annual and 2022 first quarter results. It provides the meeting time, location, participation method, and contact information. It references that the 2021 annual report and 2022 Q1 report have already been published, but this document itself is not the report or the transcript of the meeting. It is a notice about the earnings call event, not the earnings release or the transcript. Therefore, it fits best as a Call Transcript (CT) category since it is about an earnings explanation meeting, but since it is only an announcement of the meeting and not the transcript itself, it is not CT. It is also not a Report Publication Announcement (RPA) because it does not announce the release of a report but the meeting. The closest category is Call Transcript (CT) because it is about an earnings explanation meeting, but since it is only an announcement, the best fit is Regulatory Filings (RNS) as a fallback for miscellaneous announcements that do not fit other categories. Confidence is high because the document is clearly an announcement of an earnings explanation meeting, not the report or transcript itself.
2022-06-17 Chinese
马应龙独立董事关于第十一届董事会第一次会议相关审议事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent opinion from independent directors regarding the first meeting of the 11th board of directors of a company. It discusses the election of the board chairman and the appointment of senior management personnel. There is no financial data, no mention of financial results, no regulatory filings or certifications, and no indication of a report publication. The content is about board and management appointments and approvals, which fits the category of Board/Management Information (MANG). The document length is short and focused on management changes, not a full report or announcement of a report.
2022-06-14 Chinese
马应龙2021年年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2021 Annual General Meeting Resolution Announcement" for the company 马应龙药业集团股份有限公司. It details the resolutions passed at the 2021 Annual General Meeting (AGM) held on June 14, 2022, including voting results on various agenda items such as the 2021 Board Work Report, Supervisory Board Work Report, Financial Statements, Profit Distribution Plan, and election of directors and supervisors. The document includes detailed voting statistics and legal witness statements confirming the validity of the meeting and resolutions. There is no full annual report or financial statements included, only the announcement of the AGM resolutions and voting results. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 5428 characters, which is sufficient to contain detailed voting results rather than a brief announcement. Therefore, the classification is DVA with high confidence.
2022-06-14 Chinese
马应龙第十一届董事会第一次会议决议公告
Board/Management Information Classification · 100% confidence The document is a formal announcement of the resolutions passed at the first meeting of the 11th Board of Directors of 马应龙药业集团股份有限公司. It details the election of the chairman, appointment of senior management including the general manager, financial director, and board secretary, as well as the formation of various board committees and their members. The document includes personal resumes of the appointed individuals. There is no financial data, earnings information, or regulatory filings related to financial performance. The content focuses on changes and appointments in the company's board and senior management. Therefore, this document fits the category of Board/Management Information (MANG). The document length is 2646 characters, which is consistent with a detailed management announcement rather than a full report or brief notice.
2022-06-14 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.